CY1106783T1 - Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ - Google Patents

Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ

Info

Publication number
CY1106783T1
CY1106783T1 CY20071101027T CY071101027T CY1106783T1 CY 1106783 T1 CY1106783 T1 CY 1106783T1 CY 20071101027 T CY20071101027 T CY 20071101027T CY 071101027 T CY071101027 T CY 071101027T CY 1106783 T1 CY1106783 T1 CY 1106783T1
Authority
CY
Cyprus
Prior art keywords
alleviating
maintaining
fatty acid
deficiency conditions
ecosidi
Prior art date
Application number
CY20071101027T
Other languages
English (en)
Inventor
Osamu Igarashi
Kengo Akimoto
Toshiaki Yaguchi
Yoshinobu Kiso
Original Assignee
Suntory Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13065097&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106783(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Limited filed Critical Suntory Limited
Publication of CY1106783T1 publication Critical patent/CY1106783T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Μία νέα τεχνική για την ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή. Η χρησιμοποίηση υλικού που περιέχει DΡΑ για την ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και την διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή και συνθέσεων για την ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και την διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή, οι οποίες συνθέσεις περιέχουν DΡΑ-περιέχον υλικό σε μία ποσότητα αποτελεσματική στην ανακούφιση καταστάσεων ανεπάρκειας αραχιδονικού οξέος και διατήρηση ενός καλού ισοζυγίου λιπαρών οξέων εν ζωή ανά μονάδα δόσεως.
CY20071101027T 1999-03-04 2007-08-01 Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ CY1106783T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5776999 1999-03-04
PCT/JP2000/001355 WO2000051444A1 (fr) 1999-03-04 2000-03-06 Utilisation d'une matiere contenant de l'acide docosapentaenoique

Publications (1)

Publication Number Publication Date
CY1106783T1 true CY1106783T1 (el) 2012-05-23

Family

ID=13065097

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101027T CY1106783T1 (el) 1999-03-04 2007-08-01 Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ

Country Status (13)

Country Link
US (1) US6596766B1 (el)
EP (1) EP1166652B2 (el)
JP (1) JP4518674B2 (el)
KR (2) KR100504324B1 (el)
AT (1) ATE361676T2 (el)
AU (1) AU766660C (el)
CA (1) CA2362515C (el)
CY (1) CY1106783T1 (el)
DE (1) DE60034775T3 (el)
DK (1) DK1166652T4 (el)
ES (1) ES2286999T5 (el)
PT (1) PT1166652E (el)
WO (1) WO2000051444A1 (el)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094089A1 (en) * 1988-09-07 2006-05-04 Martek Biosciences Corporation Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US5340742A (en) * 1988-09-07 1994-08-23 Omegatech Inc. Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids
KR101293135B1 (ko) * 2000-01-28 2013-09-12 디에스엠 아이피 어셋츠 비.브이. 발효기 내에서 진핵 미생물의 고밀도 배양에 의한 고도불포화 지방산을 함유하는 지질의 증진된 생산 방법
ATE510908T1 (de) 2000-09-28 2011-06-15 Bioriginal Food & Science Corp Fad5-2, mitglied der desaturase-familie und verwendungen davon
US7223434B2 (en) * 2001-11-21 2007-05-29 Gerber Products Company Blended baby foods
AU2002234611A1 (en) * 2002-01-10 2003-07-24 Puleva Biotech, S.A. Oil blends
ES2221576B1 (es) * 2003-06-11 2006-03-16 Puleva Biotech, S.A. Mezclas de aceites.
US8921422B2 (en) * 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
KR20070090928A (ko) * 2004-11-19 2007-09-06 마텍 바이오싸이언스스 코포레이션 장쇄 다가불포화 지방산으로부터의 옥시리핀, 및 이의 제조방법 및 사용 방법
US7893106B2 (en) * 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
US20090318394A1 (en) * 2004-11-19 2009-12-24 Julie Nauroth Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
JP4893914B2 (ja) * 2004-12-02 2012-03-07 公立大学法人島根県立大学 経管栄養組成物
DE102005003624A1 (de) * 2005-01-26 2006-07-27 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Herstellung und Anwendung eines antioxidativ wirksamen Extraktes aus Crypthecodinium sp.
CA2611324C (en) * 2005-06-07 2017-02-14 Ocean Nutrition Canada Limited Eukaryotic microorganisms for producing lipids and antioxidants
CN103211807A (zh) * 2005-07-08 2013-07-24 Dsmip资产公司 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
EP1983977A4 (en) * 2006-01-31 2011-11-30 Martek Biosciences Corp OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2008129358A2 (en) * 2006-08-01 2008-10-30 Ocean Nutrition Canada Ltd. Oil producing microbes and methods of modification thereof
AU2007289233A1 (en) * 2006-08-29 2008-03-06 Dsm Ip Assets B.V. Use of DPA(n-6) oils in infant formula
CN101663031A (zh) * 2007-02-20 2010-03-03 马泰克生物科学公司 来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2009086281A1 (en) * 2007-12-21 2009-07-09 Martek Biosciences Corporation Method for preparation of oxylipins
WO2009102558A2 (en) * 2008-02-11 2009-08-20 Monsanto Technology Llc Aquaculture feed, products, and methods comprising beneficial fatty acids
EP2145942A1 (de) * 2008-07-15 2010-01-20 Lonza Ltd. Verfahren zur Isolierung von Ölen aus Zellen und Biomasse
DK2334295T3 (en) 2008-09-02 2017-10-09 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITION COMPREHENSIVE EICOSAPENTAIC ACID AND NICOTIC ACID AND PROCEDURES FOR USING SAME
US8207363B2 (en) * 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
WO2010127103A1 (en) 2009-04-29 2010-11-04 Amarin Pharma, Inc. Stable pharmaceutical composition and methods of using same
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
US8455472B2 (en) 2009-06-15 2013-06-04 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
KR101798670B1 (ko) 2009-09-23 2017-11-16 아마린 코포레이션 피엘씨 오메가-3 지방산 및 스타틴의 히드록시-유도체를 포함하는 제약 조성물 및 그의 사용 방법
BR112012017831B8 (pt) 2010-01-19 2021-05-25 Dsm Ip Assets Bv óleo microbiano, alimento animal e biomassa compreendendo o referido óleo microbiano
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ727980A (en) 2010-11-29 2018-08-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
AU2012285806B2 (en) 2011-07-21 2017-09-14 Dsm Ip Assets B.V. Fatty acid compositions
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
RS61557B1 (sr) 2012-06-29 2021-04-29 Amarin Pharmaceuticals Ie Ltd Postupci za smanjenje rizika od kardiovaskularnog događaja kod pacijenta na terapiji statinom primenom etil estra eikozapentaenske kiseline
US8747916B1 (en) 2012-10-30 2014-06-10 Donald M. Smith Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
AU2014229307B2 (en) 2013-03-13 2017-08-31 Dsm Nutritional Products Ag Engineering microorganisms
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2015171151A1 (en) * 2014-05-08 2015-11-12 Smith Donald M Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
AR104042A1 (es) 2015-03-26 2017-06-21 Mara Renewables Corp Producción de alta densidad de biomasa y aceite utilizando glicerol en bruto
US9951326B2 (en) 2015-07-13 2018-04-24 MARA Renewables Corporation Enhancing microbial metabolism of C5 organic carbon
JP6897917B2 (ja) * 2015-10-01 2021-07-07 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． ペットフードに用いるサプリメント素材
CN105746908B (zh) * 2016-02-23 2018-08-28 广州英赛特生物技术有限公司 肉豆蔻酸衍生物在制备动物生长促进剂中的应用
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
WO2020068163A1 (en) 2018-09-24 2020-04-02 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
SG10201900614PA (en) * 2019-01-23 2020-08-28 Agency For Science Technology And Research Astarstar Maternal DPA for benefit of mother and/or child’s mental health
WO2021132516A1 (ja) * 2019-12-26 2021-07-01 マルハニチロ株式会社 多価不飽和脂肪酸が結合したリン脂質を含む魚卵脂質組成物
KR20240012390A (ko) 2021-04-21 2024-01-29 애머린 파마슈티칼스 아일랜드 리미티드 심부전의 위험을 감소시키는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075484B2 (ja) * 1985-03-06 1995-01-25 帝人株式会社 血液脳関門通過性医薬品組成物
US5444054A (en) 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
JP3627043B2 (ja) * 1996-04-24 2005-03-09 明治乳業株式会社 ｎ−６系列／ｎ−３系列脂肪酸バランス 改善ヌクレオチド含有乳児用食品
DK0935667T3 (da) * 1996-07-23 2007-04-10 Nagase Chemtex Corp Fremgangsmåde til fremstilling af docosahexaensyre og docosapentaensyre
JP3573595B2 (ja) 1997-05-30 2004-10-06 株式会社ベルリッチ 高度不飽和脂肪酸及び／又はそのエステルを含有する組成物

Also Published As

Publication number Publication date
US6596766B1 (en) 2003-07-22
DK1166652T3 (da) 2007-09-10
KR20040014597A (ko) 2004-02-14
DE60034775D1 (de) 2007-06-21
CA2362515A1 (en) 2000-09-08
ES2286999T3 (es) 2007-12-16
AU766660C (en) 2004-05-06
EP1166652A4 (en) 2002-05-29
DE60034775T2 (de) 2008-01-17
WO2000051444A1 (fr) 2000-09-08
EP1166652B1 (en) 2007-05-09
KR20010108311A (ko) 2001-12-07
EP1166652B2 (en) 2016-07-13
ES2286999T5 (es) 2016-11-17
EP1166652A1 (en) 2002-01-02
PT1166652E (pt) 2007-08-20
DE60034775T3 (de) 2016-11-24
AU766660B2 (en) 2003-10-23
CA2362515C (en) 2008-07-15
JP4518674B2 (ja) 2010-08-04
DK1166652T4 (en) 2016-10-24
KR100504324B1 (ko) 2005-07-28
KR100423013B1 (ko) 2004-03-12
ATE361676T2 (de) 2007-06-15
AU2830600A (en) 2000-09-21

Similar Documents

Publication Publication Date Title
CY1106783T1 (el) Χρηση υλικου που περιεχει εικοσιδυ-πεντενοϊκο οξυ
CY1109626T1 (el) Ενωσεις με ιδιοτητες αποδεσμευσης αυξητικης ορμονης
TR199901077A2 (en) �spen�iyari form�lasyonlar.
WO2004049966A3 (en) Method and apparatus for bleaching teeth
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
DE69817760D1 (de) Polymerisierbare zusammensetzung für dentalanwendungen
DE69905363D1 (de) Verpackung für zahnimplantat
EA200101275A1 (ru) Композиции, содержащие креатин в суспензии
PT1185253E (pt) Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac
DE60005423D1 (de) Unterfütterungsmaterial für Zahnprothesen
ATE397922T1 (de) Lipidspiegel modulation mit steroiden und ppar- alpha agonisten
NO994431L (no) Ny formulering
PA8508301A1 (es) Inhibidores de la proteina c del procolageno
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
EP1115279A4 (en) METHOD FOR STERILIZING CYANOACRYLATE MIXTURES
TR199900872T1 (xx) Bir heteroetinilen radikali ile ba�l� bi-aromatik bile�ikler ve bunlar� ihtiva eden farmas�tik ve kozmetik kompozisyonlar.
ES2057638T3 (es) Composiciones insecticidas a base de bacillus thuringiensis.
MX9909797A (es) Composiciones para el cuidado personal que comprenden un copolimero adhesivo.
SE0203696D0 (sv) Utmatningsanordning för behållare
ES2191625T3 (es) Composicion oral que contiene perlita.
EA200000112A1 (ru) Новая композиция
IL139144A0 (en) Mycobacterial inhibitors
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну